
MediciNova
(NASDAQ) MNOV
MediciNova Financials at a Glance
Market Cap
$67.93M
Revenue (TTM)
$187.39M
Net Income (TTM)
$2.60B
EPS (TTM)
$-0.24
P/E Ratio
-5.78
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$1.38
Volume
17,835
Open
$1.39
Price
$1.38
Volume
17,835
Open
$1.39
Previous Close
$1.38
Daily Range
$1.37 - $1.39
52-Week Range
$1.17 - $1.96
Dividend
$0.00
Beta (Volatility)
0.70 (Low)
Price
$1.38
Volume
17,835
Open
$1.39
Previous Close
$1.38
Daily Range
$1.37 - $1.39
52-Week Range
$1.17 - $1.96
MNOV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MediciNova
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Yuichi Iwaki, MD, PhD
Website
www.medicinova.comHeadquarters
La Jolla, CA 92037, US
MNOV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
-5%
Net Income Margin
-14%
Return on Equity
-26%
Return on Capital
-0%
Return on Assets
-6%
Earnings Yield
-17.30%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$67.93M
Shares Outstanding
49.22M
Volume
17.84K
Avg. Volume
46.64K
Financials (TTM)
Gross Profit
$31.05K
Operating Income
$13.28M
EBITDA
$11.97M
Operating Cash Flow
$9.81M
Capital Expenditure
$0.00
Free Cash Flow
$9.81M
Cash & ST Invst.
$30.81M
Total Debt
$194.33K
MediciNova Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$186.98M
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$67.93M
N/A
Market Cap/Employee
$5.23M
N/A
Employees
13
N/A
Net Income
$2.59B
-90198.5%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$27.16B
+74905.3%
Accounts Receivable
$245.10M
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$165.20M
+86910.4%
Return on Assets
-6.08%
N/A
Return on Invested Capital
-0.03%
N/A
Free Cash Flow
$2.01M
-4.3%
Operating Cash Flow
$2.02M
-4.4%





